62.84
전일 마감가:
$66.39
열려 있는:
$65.97
하루 거래량:
252.67K
Relative Volume:
1.26
시가총액:
$956.35M
수익:
$795.49M
순이익/손실:
$62.33M
주가수익비율:
126.51
EPS:
0.4967
순현금흐름:
$67.97M
1주 성능:
+0.02%
1개월 성능:
+0.05%
6개월 성능:
-20.17%
1년 성능:
-15.59%
U S Physical Therapy Inc Stock (USPH) Company Profile
명칭
U S Physical Therapy Inc
전화
(713) 297-7000
주소
1300 WEST SAM HOUSTON PARKWAY SOUTH, HOUSTON, TX
Compare USPH vs HCA, THC, DVA, FMS, EHC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
USPH
U S Physical Therapy Inc
|
62.84 | 997.14M | 795.49M | 62.33M | 67.97M | 0.4967 |
|
HCA
Hca Healthcare Inc
|
388.16 | 86.51B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
178.50 | 15.43B | 21.46B | 2.65B | 3.35B | 19.23 |
|
DVA
Davita Inc
|
210.58 | 13.46B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.57 | 12.60B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
97.89 | 9.86B | 6.07B | 793.80M | 464.40M | 5.9914 |
U S Physical Therapy Inc Stock (USPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-10 | 재개 | Jefferies | Buy |
| 2025-09-18 | 재개 | JP Morgan | Overweight |
| 2024-12-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-12-16 | 개시 | JMP Securities | Mkt Outperform |
| 2024-10-07 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-09-22 | 개시 | JP Morgan | Overweight |
| 2023-06-30 | 개시 | BofA Securities | Buy |
| 2021-12-14 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2021-08-06 | 재확인 | Barrington Research | Outperform |
| 2021-05-07 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-05-03 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-02-26 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-06-08 | 재확인 | Barrington Research | Outperform |
| 2020-04-30 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-03-11 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-02-28 | 재확인 | Barrington Research | Outperform |
| 2019-11-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2019-03-08 | 개시 | William Blair | Outperform |
| 2017-11-03 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2017-09-08 | 업그레이드 | Sidoti | Neutral → Buy |
| 2017-07-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2017-03-17 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-11-04 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2016-08-05 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-05-06 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2016-03-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-11-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2015-05-06 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2013-12-12 | 재확인 | Dougherty & Company | Buy |
| 2013-08-23 | 재확인 | Dougherty & Company | Buy |
| 2013-01-14 | 재확인 | Dougherty & Company | Buy |
| 2010-07-09 | 개시 | JMP Securities | Mkt Outperform |
모두보기
U S Physical Therapy Inc 주식(USPH)의 최신 뉴스
From clinic mainstay to investor talking point, USPH’s outpatient physical therapy sets its pace - AD HOC NEWS
USPH Q1 2026 Earnings: EPS Misses Estimates by 17.25%, Stock Edge LowerPeak Earnings Alert - newsline.com
NewtekOne Fixed-Rate Notes (NEWTI) Hold Steady at $25.19 Amid Stable TradingInsider Buying Alerts - newsline.com
U.S. Physical Therapy Stock (US9175021020): Insider buying as shares trade near 52-week low - AD HOC NEWS
Hodges Capital Management Inc. Acquires Shares of 35,105 U.S. Physical Therapy, Inc. $USPH - MarketBeat
Insider Buying: Peter Minan Acquires Shares of US Physical Thera - GuruFocus
U.S. Physical Therapy (USPH) Gains 1.67% as It Bounces Off Support; Key Resistance in SightSynthetic Short - newsline.com
Insider Buying: U.S. Physical Therapy (NYSE:USPH) Director Acquires 288 Shares of Stock - MarketBeat
U.S. physical therapy director Peter Minan acquires $48,776 in stock By Investing.com - Investing.com India
Peter Francis Minan Acquires 492 Shares of U.S. Physical Therapy (NYSE:USPH) Stock - MarketBeat
U.S. physical therapy director Peter Minan acquires $48,776 in stock - Investing.com
US Physical Therapy (USPH) director adds 780 shares in open-market buys - Stock Titan
Technical Reactions to USPH Trends in Macro Strategies - Stock Traders Daily
USPH Technical Analysis & Stock Price Forecast - Intellectia AI
USPH Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock MovementPost-Earnings Drift - newsline.com
USPH Q1 2026 Earnings: EPS Misses Estimates by 17.25%, Stock Rises 2.72%Return On Capital - newsline.com
Stock List: Research Stocks from Around the World - GuruFocus
USPH Slips 1.25% as Support Levels Loom: U.S. Physical Therapy (USPH) in FocusThematic ETF Flow - newsline.com
How The Story Is Shifting For U.S. Physical Therapy (USPH) As Price Targets Reset - Yahoo Finance
USPH Q1 2026 Earnings: EPS Misses Estimates by 17.25%, Stock DeclinesCash Flow Report - newsline.com
U.S. Physical Therapy (USPH) director receives 2,306-share restricted stock grant - Stock Titan
Director at U.S. Physical Therapy (NYSE: USPH) receives 2,306 restricted shares - Stock Titan
US Physical Therapy (NYSE: USPH) director receives 2,306 restricted stock shares - Stock Titan
Director at U S Physical Therapy (NYSE: USPH) granted 2,306 shares - Stock Titan
U.S. Physical Therapy (NYSE: USPH) director receives 2,306-share stock grant - Stock Titan
USPH Q1 2026 Earnings: EPS Misses Estimates by 17.25%, Stock Rises 3.3%Non-GAAP Earnings - The Legal Advocate
USPH Q1 2026 Earnings: EPS Misses Estimates by 17.25% but Stock Gains 3.32%Investor Earnings Call - The Legal Advocate
Trading the Move, Not the Narrative: (USPH) Edition - Stock Traders Daily
U.S. Physical Therapy (USPH) Edges Higher Near Resistance as Sector Trends Remain SupportiveDescending Triangle - The Legal Advocate
U.S. Physical Therapy (USPH) Holds Steady Near $62 as Support Levels TestedPCR Extreme - The Legal Advocate
USPH Q1 2026 Earnings: Earnings Miss Expectations as EPS Falls Short by 17.25%Return On Capital - newsline.com
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
USPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
USPH Q1 2026 Earnings: EPS Misses Estimates by Over 17%, Stock DeclinesNet Profit Margin - The Legal Advocate
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade) (NYSE:USPH) - Seeking Alpha
USPH Q1 2026 Earnings: EPS Miss Weighs on Investor Sentiment Despite Operational ConsistencyEBITDA Estimate Trend - newsline.com
U.S. Physical Therapy Stock Stagnates at $65.04, Underperforms S&P 500News and Statistics - IndexBox
3 Reasons USPH is Risky and 1 Stock to Buy Instead - Yahoo Finance
Director at U S Physical Therapy (NYSE: USPH) receives stock grant - Stock Titan
U.S. Physical Therapy shareholders approve all proposals at annual meeting - Investing.com India
U.S. Physical Therapy shareholders approve all proposals at annual meeting By Investing.com - Investing.com India
U.S. Physical Therapy (USPH) director granted 2,306 restricted shares at $61.61 - Stock Titan
[Form 4] U S PHYSICAL THERAPY INC /NV Insider Trading Activity - Stock Titan
US Physical Therapy (USPH) awards 2,306 restricted shares to director Harris - Stock Titan
U.S. Physical Therapy (USPH) director granted 2,306 restricted shares as equity pay - Stock Titan
US Physical Therapy Shareholders Back Board, Pay, Auditor - The Globe and Mail
USPH (USPH) director Peter Minan discloses initial 125-share stake - Stock Titan
[8-K] U S PHYSICAL THERAPY INC /NV Reports Material Event - Stock Titan
U.S. Physical Therapy, Inc. Approves Election of Peter F. Minan as Director - marketscreener.com
US Physical Therapy (USPH) Q1 earnings and revenues lag estimates - MSN
Why It Might Not Make Sense To Buy U.S. Physical Therapy, Inc. (NYSE:USPH) For Its Upcoming Dividend - simplywall.st
U S Physical Therapy Inc (USPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):